Separate magnesium assay adjustment, process loss and formulation overage

Name the adjustment before calculating it

An assay adjustment changes ingredient mass to account for the accepted elemental magnesium concentration. A process-loss allowance plans material for an expected manufacturing yield. An intentional overage increases the formulated amount above the stated target for a justified purpose. These should appear as separate assumptions in the technical record.

For U.S. dietary supplements, the master manufacturing record requirements include a statement of any intentional dietary-ingredient overage and relevant theoretical-yield information. [1] For technical review, also record the evidence and rationale behind the chosen amount rather than leaving an unexplained spreadsheet multiplier.

Agree who authorizes each adjustment and how it affects the approved formula. A purchasing quantity, a dispensed batch quantity and a label amount serve different purposes and should not silently replace one another.

Work through the quantities on a common basis

Consider a teaching example of 10,000 servings, each with a formulation target of 100 mg elemental magnesium. The total elemental requirement is 1,000,000 mg, or 1 kg. At an accepted as-is assay of 10.0%, the magnesium ingredient requirement is 10 kg. At 9.8%, it becomes approximately 10.204 kg: 1 kg divided by 0.098.

The additional 0.204 kg is an assay correction to reach the same elemental target; it is not a 2.04% elemental overage. Before applying the calculation, confirm that the assay is appropriate for batch adjustment and uses the same mass basis as the dispensed material.

On smaller screens, scroll the table horizontally.

Investigate loss before changing concentration

If the whole blend is lost uniformly during transfer, producing more of the same blend may address the unit-count requirement. If one component is lost preferentially or the blend segregates, that assumption fails. Increasing only the magnesium ingredient could change the composition of units that were already within target.

Reconcile dispensed mass, recovered blend, rejected units, retained samples and finished yield. Link concentration data to the same production stages. A low number of saleable units is not automatically evidence of low magnesium concentration in those units.

Also check the analytical chain: sampling, homogenization, digestion, dilution, reporting units and as-is versus dry-basis interpretation. Resolve an inconsistent result before building it into the next master formula.

Support an overage with the product's own evidence

Evaluate the proposed amount against observed manufacturing variation, the finished-product specification and the intended shelf-life claim. Do not assume a mineral formula needs the same allowance as a vitamin or botanical product. Establish what is actually changing in the tested product and why.

A shelf-life date needs supporting evidence. FDA has specifically reminded dietary supplement firms that voluntarily used expiration or best-by dates should be backed by data [2].

Keep the approved formula, actual batch adjustments, finished results and stability observations connected. When discussing a grade with a supplier, provide the target elemental amount, accepted assay basis, unit format and the specific variation you need to understand.

Common questions